The antiviral enzymes PKR and RNase L suppress exogenous gene expression, suggesting that inhibiting these enzymes could selectively increase expression from gene therapy vectors.
No takes yet. Share an insight, caveat, or question.
Targeting RNase L/PKR may boost gene therapy vectors; animal data leave open human translation.
Terenzi et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: